Oseltamivir Phosphate

磷酸奥司他韦

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameOseltamivir Phosphate
Drug Alias Name磷酸奥塞米韦oseltamivir奥塞米韦oseltamivirum奥他米韦 +[16] 
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Prodrug
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsObesityPurpura, Thrombocytopenic, Idiopathic +[6] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritorySwitzerland
Original Approved Date1999/09/21
Country/TerritoryCzechiaBelgiumBulgaria +[41] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche LtdGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesRoche Pharma (Switzerland) LtdChugai Pharmaceutical Co LtdF. Hoffmann-La Roche Ltd +[5] 
Inactive CompaniesHanmi Pharmaceutical Co LtdLi Ka Shing Knowledge InstituteUniversity of Toronto +[10] 
Active IndicationsInfluenza, Human
Inactive IndicationsInfluenza A virus infectionsObesityPurpura, Thrombocytopenic, Idiopathic +[5] 

Other Information

ATC CodeJ05AH02
Related LinksWikipediaDrugBankKEGG